Larry Robbins’ Glenview Capital Management’s Opportunity Fund delivered 7.2% during the first quarter, significantly outperforming the S&P 500. In this article, I’m taking a closer look at some of the fund’s top calls during the quarter and outlook for the rest of the year. If you’re interested in a condensed version of the fund’s performance during the quarter, ValueWalk author, Mark Melin has put together a brief overview here. Glenview: AbbVie After talking up AbbVie at the Sohn Conference earlier this year, Larry Robbins continued to tout the stock in Glenview’s first quarter letter. Robbins says that he sees a…
Glenview Likes AbbVie, Brookdale And Marty Lipton
Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway. Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK. Rupert covers everything value investing for ValueWalk